Adenovirus vector-based vaccine for infectious diseases.
Sakurai F, Tachibana M, Mizuguchi H.
Drug Metab Pharmacokinet. 2022 Feb;42:100432. doi: 10.1016/j.dmpk.2021.100432. Epub 2021 Nov 12.
Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy.
Watanabe M, Nishikawaji Y, Kawakami H, Kosai KI.
Viruses. 2021 Dec 14;13(12):2502. doi: 10.3390/v13122502.
Simian adenoviral pneumonia.
Boyce JT, Giddens WE Jr, Valerio M.
Am J Pathol. 1978 May;91(2):259-76.
Adenoviral pneumonia in a foal.
Whitlock RH, Dellers RW, Shively JN.
Cornell Vet. 1975 Jul;65(3):393-401.
Healthcare-associated atypical pneumonia.
Forgie S, Marrie TJ.
Semin Respir Crit Care Med. 2009 Feb;30(1):67-85. doi: 10.1055/s-0028-1119811. Epub 2009 Feb 6.
Adenovirus pneumonia.
BLATTNER RJ.
J Pediatr. 1958 Nov;53(5):631-3. doi: 10.1016/s0022-3476(58)80155-9.
SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.
Swets MC, Russell CD, Harrison EM, Docherty AB, Lone N, Girvan M, Hardwick HE; ISARIC4C Investigators; Visser LG, Openshaw PJM, Groeneveld GH, Semple MG, Baillie JK.
Lancet. 2022 Apr 16;399(10334):1463-1464. doi: 10.1016/S0140-6736(22)00383-X. Epub 2022 Mar 25.
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19.
Afkhami S, Kang A, Jeyanathan V, Xing Z, Jeyanathan M.
Curr Opin Virol. 2023 Aug;61:101334. doi: 10.1016/j.coviro.2023.101334. Epub 2023 May 11.
Respiratory Viruses in Nosocomial Pneumonia: An Evolving Paradigm.
Zilberbeg MD, Khan I, Shorr AF.
Viruses. 2023 Jul 31;15(8):1676. doi: 10.3390/v15081676.
COVID-19 vaccine-induced thrombotic thrombocytopenia: Adverse event associated with adenovirus vector-based vaccines.
Pottie K, Hin ANC, Saad A.
Can Fam Physician. 2022 Jun;68(6):434-437. doi: 10.46747/cfp.6806434.
